SI0848720T1 - Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers - Google Patents

Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers

Info

Publication number
SI0848720T1
SI0848720T1 SI9630666T SI9630666T SI0848720T1 SI 0848720 T1 SI0848720 T1 SI 0848720T1 SI 9630666 T SI9630666 T SI 9630666T SI 9630666 T SI9630666 T SI 9630666T SI 0848720 T1 SI0848720 T1 SI 0848720T1
Authority
SI
Slovenia
Prior art keywords
cancers
antagonists
treatment
oncogenic activity
protein mdm2
Prior art date
Application number
SI9630666T
Other languages
Slovenian (sl)
Inventor
Bruno Tocque
Marie-Christine Dubs-Poterszman
Bohdan Wasylyk
Original Assignee
Aventis Pharma S.A.
Institut National De La Sante Et
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510331A external-priority patent/FR2738151B1/en
Application filed by Aventis Pharma S.A., Institut National De La Sante Et filed Critical Aventis Pharma S.A.
Publication of SI0848720T1 publication Critical patent/SI0848720T1/en

Links

SI9630666T 1995-09-04 1996-09-02 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers SI0848720T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510331A FR2738151B1 (en) 1995-09-04 1995-09-04 ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE MDM2 PROTEIN, AND THEIR USE IN THE TREATMENT OF CANCERS
EP96930195A EP0848720B1 (en) 1995-09-04 1996-09-02 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
PCT/FR1996/001340 WO1997009343A2 (en) 1995-09-04 1996-09-02 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers

Publications (1)

Publication Number Publication Date
SI0848720T1 true SI0848720T1 (en) 2004-04-30

Family

ID=32178718

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630666T SI0848720T1 (en) 1995-09-04 1996-09-02 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers

Country Status (1)

Country Link
SI (1) SI0848720T1 (en)

Similar Documents

Publication Publication Date Title
HUP9900406A3 (en) Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
EG24144A (en) Disubstituted bicyclic heterocycles their preparation and their use as medicaments
EP1070080A4 (en) HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE
PL329411A1 (en) Novel derivatives of benzazepin, therapeutic agents containing such derivatives and their application in production of therapeutic agents
AU4378196A (en) Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
ZA9610784B (en) Quinoline and quinazoline compounds useful in therapy.
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
IL120477A0 (en) Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
HUT74608A (en) Biologically active silicon-compounds and their pharmaceutical and cosmetical use
GB9712761D0 (en) Quinolines and their therapeutic use
HUP9700661A3 (en) Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer
ZA943549B (en) Cell surface protein expressed on human cortical thymocyte and their use
ZA983740B (en) Novel amidine derivatives and their use in therapy
AU4324089A (en) Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product
HUP0002329A3 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
HRP960117B1 (en) Bicyclic compounds, their preparation and use in pharmaceutical preparations
AU3116697A (en) Human interleukin-1j and antagonists thereof
SI0848720T1 (en) Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
AU5871898A (en) Microparticles and their use in cancer treatment
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
EP0540575A4 (en) Human meg-csf protein and methods